- Home
- IGMS vs LVO Comparison
IGMS vs LVO Comparison
Compare IGMS & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- LVO
- Stock Information
- Founded
- IGMS 1993
- LVO 2009
- Country
- IGMS United States
- LVO United States
- Employees
- IGMS N/A
- LVO N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- LVO Restaurants
- Sector
- IGMS Health Care
- LVO Consumer Discretionary
- Exchange
- IGMS Nasdaq
- LVO Nasdaq
- Market Cap
- IGMS 82.1M
- LVO 79.4M
- IPO Year
- IGMS 2019
- LVO N/A
- Fundamental
- Price
- IGMS $1.22
- LVO $0.64
- Analyst Decision
- IGMS Hold
- LVO Strong Buy
- Analyst Count
- IGMS 8
- LVO 2
- Target Price
- IGMS $6.14
- LVO $2.75
- AVG Volume (30 Days)
- IGMS 167.6K
- LVO 330.5K
- Earning Date
- IGMS 05-07-2025
- LVO 05-29-2025
- Dividend Yield
- IGMS N/A
- LVO N/A
- EPS Growth
- IGMS N/A
- LVO N/A
- EPS
- IGMS N/A
- LVO N/A
- Revenue
- IGMS $2,679,000.00
- LVO $126,016,000.00
- Revenue This Year
- IGMS $121.76
- LVO $0.69
- Revenue Next Year
- IGMS $46.83
- LVO N/A
- P/E Ratio
- IGMS N/A
- LVO N/A
- Revenue Growth
- IGMS 25.77
- LVO 11.43
- 52 Week Low
- IGMS $0.92
- LVO $0.55
- 52 Week High
- IGMS $22.50
- LVO $1.99
- Technical
- Relative Strength Index (RSI)
- IGMS 47.65
- LVO 42.64
- Support Level
- IGMS $1.16
- LVO $0.62
- Resistance Level
- IGMS $1.31
- LVO $0.69
- Average True Range (ATR)
- IGMS 0.12
- LVO 0.07
- MACD
- IGMS 0.03
- LVO 0.00
- Stochastic Oscillator
- IGMS 76.92
- LVO 48.13
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.